SYNVISTA THERAPEUTICS INC has a total of 19 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are THESAN PHARMACEUTICALS INC, REVISION THERAPEUTICS INC and ONCOCEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Berkowitz Noah | 7 |
#2 | Vasan Sara | 5 |
#3 | Wagle Dilip | 5 |
#4 | Egan John J | 4 |
#5 | Forbes Josephine | 3 |
#6 | Fang Sheng Ding | 3 |
#7 | Levy Andrew | 3 |
#8 | Gall Martin | 3 |
#9 | Thomas Merlin | 2 |
#10 | Victor Jacob | 2 |
Publication | Filing date | Title |
---|---|---|
WO2009152319A1 | Reagents and methods for detecting a polymorphic protein | |
WO2009051804A1 | Thiazolium compounds for treating or preventing diseases associated with insulin resistance | |
WO2009042213A1 | Methods of treating or preventing cardiac disease associated with a high fat diet | |
WO2009023207A1 | Thiazolium compounds for treating gastrointestinal complications | |
WO2008143883A1 | Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (rct) | |
WO2008100629A2 | Glutathione peroxidase mimetics for the treatment of dermatoses | |
WO2008100628A2 | Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |